Orthopedic implant pricing is under sustained pressure from hospital value analysis committees, GPO contract requirements, and the shift toward bundled payment reimbursement. Surgeon preference items — implants selected by surgeons rather than hospital procurement — represent the most commercially valuable and most contested category in orthopedic contracting. This report covers pricing dynamics, contracting strategies, and margin management across the global orthopedics industry.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Table of Contents
1. Executive Summary
2. Overview
3. GPO Contracting Strategy
4. IDN and Hospital System Contracting
5. Surgeon Preference and Pricing
6. Value-Based Contracting
7. International Pricing
8. Distributor Economics
9. Pricing Trends 2026-2028
10. Strategic Recommendations
11. Competitive Landscape
12. Strategic Conclusions and Recommendations
13. Appendix
List of Tables
Table 1. Overview and Key Data 2025
Table 2-8. Topic-Specific Analysis Tables
Table 2. Leading Suppliers — Strategy Assessment 2025
Table 3. Key Risks and Mitigation Strategies
Companies Profiled
Aesculap
Arthrex
DePuy Synthes
Enovis
Globus Medical
NuVasive
Smith & Nephew
Stryker
Wright Medical
Zimmer Biomet
